|
1
|
Bouhassira D and Attal N: Translational
neuropathic pain research: A clinical perspective. Neuroscience.
338:27–35. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Finnerup NB, Haroutounian S, Kamerman P,
Baron R, Bennett DL, Bouhassira D, Cruccu G, Freeman R, Hansson P,
Nurmikko T, et al: Neuropathic pain: An updated grading system for
research and clinical practice. Pain. 157:1599–1606. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW,
Gong DJ, Sun YM, Lu ZJ and Yu WF: Intrathecal siRNA against
Toll-like receptor 4 reduces nociception in a rat model of
neuropathic pain. Int J Med Sci. 7:251–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lefaucheur JP: Cortical neurostimulation
for neuropathic pain: State of the art and perspectives. Pain. 157
Suppl 1:S81–S89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen D, Weng Y, Ouyang B, Guo M and Guo Q:
Effect of intrathecal ropivacaine on spinal HDAC1 and HDAC2
expression in rats with neuropathic pain. Chin J Anaesth.
35:1093–1095. 2015.(In Chinese).
|
|
6
|
Maiarù M, Morgan OB, Tochiki KK, Hobbiger
EJ, Rajani K, Overington DW and Géranton SM: Complex regulation of
the regulator of synaptic plasticity histone deacetylase 2 in the
rodent dorsal horn after peripheral injury. J Neurochem.
138:222–232. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai D, Zhang Y, Shen M, Sun Y, Xia Q,
Zhang Y, Liu X, Wang H and Yuan L: Hyperglycemia and hyperlipidemia
blunts the Insulin-Inpp5f negative feedback loop in the diabetic
heart. Sci Rep. 6:220682016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Palermo G, Maisel D, Barrett M, Smith H,
Duchateau-Nguyen G, Nguyen T, Yeh RF, Dufour A, Robak T, Dornan D,
et al: REACH investigators: Gene expression of INPP5F as an
independent prognostic marker in fludarabine-based therapy of
chronic lymphocytic leukemia. Blood Cancer J. 5:e3532015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Toth C: Pregabalin: Latest safety evidence
and clinical implications for the management of neuropathic pain.
Ther Adv Drug Saf. 5:38–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Verma V, Singh N and Singh Jaggi A:
Pregabalin in neuropathic pain: Evidences and possible mechanisms.
Curr Neuropharmacol. 12:44–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bennett GJ and Xie YK: A peripheral
mononeuropathy in rat that produces disorders of pain sensation
like those seen in man. Pain. 33:87–107. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang BC, Cao DL, Zhang X, Zhang ZJ, He
LN, Li CH, Zhang WW, Wu XB, Berta T, Ji RR, et al: CXCL13 drives
spinal astrocyte activation and neuropathic pain via CXCR5. J Clin
Invest. 126:745–761. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim J, Ryu SB, Lee SE, Shin J, Jung HH,
Kim SJ, Kim KH and Chang JW: Motor cortex stimulation and
neuropathic pain: How does motor cortex stimulation affect
pain-signaling pathways? J Neurosurg. 124:866–876. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang SE, Ko SY, Jo S, Choi M, Lee SH, Jo
HR, Seo JY, Lee SH, Kim YS, Jung SJ, et al: TRPV1 regulates stress
responses through HDAC2. Cell Rep. 19:401–412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim HS, Li A, Ahn S, Song H and Zhang W:
Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3
activity and suppresses gliomas tumorigenicity. Sci Rep.
4:73302014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakatsu F, Messa M, Nández R, Czapla H,
Zou Y, Strittmatter SM and De Camilli P: Sac2/INPP5F is an inositol
4-phosphatase that functions in the endocytic pathway. J Cell Biol.
209:85–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zou Y, Stagi M, Wang X, Yigitkanli K,
Siegel CS, Nakatsu F, Cafferty WB and Strittmatter SM:
Gene-silencing screen for mammalian axon regeneration identifies
Inpp5f (Sac2) as an endogenous suppressor of repair after spinal
cord injury. J Neurosci. 35:10429–10439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang S, Sarmiere PD, Doolen S, Kluge B,
Huang F, White JT and Holmberg E: Scar ablation combined with cell
transplantation promotes tissue repair and axon regeneration in
chronic contusion injury of rat spinal cord. 25th Annual
National-Neurotrauma-Society Symposium. 24:12562007.
|
|
20
|
Lu Y, Jiang BC, Cao DL, Zhang ZJ, Zhang X,
Ji RR and Gao YJ: TRAF6 upregulation in spinal astrocytes maintains
neuropathic pain by integrating TNF-α and IL-1β signaling. Pain.
155:2618–2629. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Khan J, Noboru N, Young A and Thomas D:
Pro- and anti-inflammatory cytokine levels (TNF-α, IL-1β, IL-6 and
IL-10) in rat model of neuroma. Pathophysiology. 24:155–159. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan Y, Peng W, Liu Y and Xu Z: Palmatine
attenuates isoproterenol-induced pathological hypertrophy via
selectively inhibiting HDAC2 in rats. Int J Immunopathol Pharmacol.
30:406–412. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trivedi CM, Luo Y, Yin Z, Zhang M, Zhu W,
Wang T, Floss T, Goettlicher M, Noppinger PR, Wurst W, et al: Hdac2
regulates the cardiac hypertrophic response by modulating Gsk3 beta
activity. Nat Med. 13:324–331. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma H, Marti-Gutierrez N, Park SW, Wu J,
Lee Y, Suzuki K, Koski A, Ji D, Hayama T, Ahmed R, et al:
Correction of a pathogenic gene mutation in human embryos. Nature.
548:413–419. 2017. View Article : Google Scholar : PubMed/NCBI
|
